This project addresses the molecular mechanisms underlying signal transduction and regulation of muscarinic cholinergic receptors. During the previous project period, the m1, m2, and m3 receptors were modified by site-directed mutagenesis to define domains relevant to second messenger signaling, internalization, and downregulation. The present proposal focuses on the direct interactions of the muscarinic receptors with proteins involved in receptor functions. These include a) coupling to specific G proteins, b) membrane-delimited interactions with ion channels, c) phosphorylation by protein kinases, and d) aggregation among the receptors themselves and with other membrane proteins. Aggregation of integral membrane proteins is thermodynamically favored, and G protein coupled receptors and ion channels tends to form homo-oligomers (as reported for the m2 receptor) or hetero-oligomers. Hetero-aggregation has not been adequately investigated for G protein-coupled receptors; yet, aggregates may play essential roles in all receptor functions. Methodologies will be developed to study receptor aggregation, using biophysical, biochemical, aand genetic approaches in order to understand receptor function at the quaternary structural level of membrane protein organization. This study should also address the question as to whether muscarinic receptors can assume multiple conformations, each signalling along distinct pathways. The expected insights from the studies outlined in this proposal should assist in the design of cholinergic therapy for cognitive disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM043102-11
Application #
6329715
Study Section
Neurology C Study Section (NEUC)
Program Officer
Cole, Alison E
Project Start
1989-12-01
Project End
2002-04-01
Budget Start
2000-12-01
Budget End
2002-04-01
Support Year
11
Fiscal Year
2001
Total Cost
$187,125
Indirect Cost
Name
University of California San Francisco
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Brown, Shoshana; Chang, Jean L; Sadee, Wolfgang et al. (2003) A semiautomated approach to gene discovery through expressed sequence tag data mining: discovery of new human transporter genes. AAPS PharmSci 5:E1
Salvi, Aline; Quillan, J Mark; Sadee, Wolfgang (2002) Monitoring intracellular pH changes in response to osmotic stress and membrane transport activity using 5-chloromethylfluorescein. AAPS PharmSci 4:E21
Quillan, J Mark; Carlson, Kurt W; Song, Chunyan et al. (2002) Differential effects of mu-opioid receptor ligands on Ca(2+) signaling. J Pharmacol Exp Ther 302:1002-12
Lin, Kedan; Wang, Danxin; Sadee, Wolfgang (2002) Serum response factor activation by muscarinic receptors via RhoA. Novel pathway specific to M1 subtype involving calmodulin, calcineurin, and Pyk2. J Biol Chem 277:40789-98
Dickson, Robert C; Lester, Robert L (2002) Sphingolipid functions in Saccharomyces cerevisiae. Biochim Biophys Acta 1583:13-25
Lucas, J L; DeYoung, J A; Sadee, W (2001) Single nucleotide polymorphisms of the human M1 muscarinic acetylcholine receptor gene. AAPS PharmSci 3:E31
Belcheva, M M; Szucs, M; Wang, D et al. (2001) mu-Opioid receptor-mediated ERK activation involves calmodulin-dependent epidermal growth factor receptor transactivation. J Biol Chem 276:33847-53
Graul, R C; Sadee, W (2001) Evolutionary relationships among G protein-coupled receptors using a clustered database approach. AAPS PharmSci 3:E12
Choi, D S; Wang, D; Tolbert, L et al. (2000) Basal signaling activity of human dopamine D2L receptor demonstrated with an ecdysone-inducible mammalian expression system. J Neurosci Methods 94:217-25
Kassack, M U; Hogger, P; Gschwend, D A et al. (2000) Molecular modeling of G-protein coupled receptor kinase 2: docking and biochemical evaluation of inhibitors. AAPS PharmSci 2:E2

Showing the most recent 10 out of 38 publications